Exhibit 107
CALCULATION OF REGISTRATION FEE
Form S-8
(Form Type)
Intellia Therapeutics, Inc.
(Exact name of Registrant as Specified in its Charter)
Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Maximum Price | Fee Rate | Amount of Registration Fee | |||||||
| Equity | Common Stock, $0.0001 par value per share, reserved for issuance pursuant to the Intellia Therapeutics, Inc. 2024 Inducement Plan | Other | 850,000 shares (2) | $26.72 (3) | $22,712,000 (3) | $0.00014760 | $3,352.29 | |||||||
| Total Offering Amounts | $22,712,000 | — | ||||||||||||
| Total Fees Previously Paid | — | |||||||||||||
| Total Fee Offsets | — | |||||||||||||
| Net Fee Due | $3,352.29 | |||||||||||||
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions effected without the receipt of consideration which results in an increase in the number of our outstanding shares of common stock. |
| (2) | Represents 850,000 shares of Intellia Therapeutics, Inc. Common Stock reserved for issuance under the Intellia Therapeutics, Inc. 2024 Inducement Plan. |
| (3) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended. The price per share and aggregate offering price are calculated on the basis of $26.72, the average of the high and low price of the registrant’s Common Stock as reported on the NASDAQ Global Market on July 16, 2024. |
